Single-disease health campaigns: the case of cervical cancer – Authors' reply
[...] the best-case scenario presented is a decline of 30% in cervical cancer deaths. Visual inspection with acetic acid (VIA) or human papillomavirus (HPV) vaccine programmes save money.2 The US$0.23 figure mentioned covers materials for screening and treatment (cotton, vinegar, batteries, CO2).3 V...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2011-10, Vol.378 (9800), p.1378-1378 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1378 |
---|---|
container_issue | 9800 |
container_start_page | 1378 |
container_title | The Lancet (British edition) |
container_volume | 378 |
creator | Burns, August Sanghvi, Harshad Lu, Ricky Gaffikin, Lynne Blumenthal, Paul |
description | [...] the best-case scenario presented is a decline of 30% in cervical cancer deaths. Visual inspection with acetic acid (VIA) or human papillomavirus (HPV) vaccine programmes save money.2 The US$0.23 figure mentioned covers materials for screening and treatment (cotton, vinegar, batteries, CO2).3 VIA requires only a flashlight; cryotherapy requires no electricity. |
doi_str_mv | 10.1016/S0140-6736(11)61610-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_900104665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0140673611616103</els_id><sourcerecordid>2492178231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c254t-9ded50dc11cc18eb50ca92179d53561ea9e989036429cf126b237b03163157703</originalsourceid><addsrcrecordid>eNqFkE1OwzAQhS0EEqVwBKSIDbAIzMSx07AAIcSfhNRFQWJnuc6EGNKk2Gml7rgDN-QkuC1iwYaVx5433_g9xvYRThBQno4AU4hlxuUR4rFEiRDzDdbDNEtjkWbPm6z3K9lmO96_AkAqQfTYcGSbl5riwnrSnqKKdN1VkdGTqbYvjT-LuorCNbTaMjLk5tboOjw0oY6-Pj6jy1lXtc4fRo6m9WKXbZW69rT3c_bZ083149Vd_DC8vb-6fIhNItIuzgsqBBQG0Rgc0FiA0XmCWV4ILiSSzikf5MBlmuSmxESOE56NgaPkKLIMeJ8drLlT177PyHfqtZ25JqxUOQAGd1IEkViLjGu9d1SqqbMT7RYKQS2jU6vo1DIXhahW0Ske5i7WcxQczC055Y2l4Liwjkynitb-Szj_QzC1bZbRvdGC_O9fUflEwRqyZCCuCJx_A6IbiVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>900104665</pqid></control><display><type>article</type><title>Single-disease health campaigns: the case of cervical cancer – Authors' reply</title><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central</source><creator>Burns, August ; Sanghvi, Harshad ; Lu, Ricky ; Gaffikin, Lynne ; Blumenthal, Paul</creator><creatorcontrib>Burns, August ; Sanghvi, Harshad ; Lu, Ricky ; Gaffikin, Lynne ; Blumenthal, Paul</creatorcontrib><description>[...] the best-case scenario presented is a decline of 30% in cervical cancer deaths. Visual inspection with acetic acid (VIA) or human papillomavirus (HPV) vaccine programmes save money.2 The US$0.23 figure mentioned covers materials for screening and treatment (cotton, vinegar, batteries, CO2).3 VIA requires only a flashlight; cryotherapy requires no electricity.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(11)61610-3</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Acetic acid ; Carbon dioxide ; Cervical cancer ; Costs ; Developing countries ; Disease ; Health promotion ; Health services ; Human papillomavirus ; Internal Medicine ; LDCs ; Mortality ; Reproductive health ; Womens health</subject><ispartof>The Lancet (British edition), 2011-10, Vol.378 (9800), p.1378-1378</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Oct 15-Oct 21, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c254t-9ded50dc11cc18eb50ca92179d53561ea9e989036429cf126b237b03163157703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/900104665?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64389,72469</link.rule.ids></links><search><creatorcontrib>Burns, August</creatorcontrib><creatorcontrib>Sanghvi, Harshad</creatorcontrib><creatorcontrib>Lu, Ricky</creatorcontrib><creatorcontrib>Gaffikin, Lynne</creatorcontrib><creatorcontrib>Blumenthal, Paul</creatorcontrib><title>Single-disease health campaigns: the case of cervical cancer – Authors' reply</title><title>The Lancet (British edition)</title><description>[...] the best-case scenario presented is a decline of 30% in cervical cancer deaths. Visual inspection with acetic acid (VIA) or human papillomavirus (HPV) vaccine programmes save money.2 The US$0.23 figure mentioned covers materials for screening and treatment (cotton, vinegar, batteries, CO2).3 VIA requires only a flashlight; cryotherapy requires no electricity.</description><subject>Acetic acid</subject><subject>Carbon dioxide</subject><subject>Cervical cancer</subject><subject>Costs</subject><subject>Developing countries</subject><subject>Disease</subject><subject>Health promotion</subject><subject>Health services</subject><subject>Human papillomavirus</subject><subject>Internal Medicine</subject><subject>LDCs</subject><subject>Mortality</subject><subject>Reproductive health</subject><subject>Womens health</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1OwzAQhS0EEqVwBKSIDbAIzMSx07AAIcSfhNRFQWJnuc6EGNKk2Gml7rgDN-QkuC1iwYaVx5433_g9xvYRThBQno4AU4hlxuUR4rFEiRDzDdbDNEtjkWbPm6z3K9lmO96_AkAqQfTYcGSbl5riwnrSnqKKdN1VkdGTqbYvjT-LuorCNbTaMjLk5tboOjw0oY6-Pj6jy1lXtc4fRo6m9WKXbZW69rT3c_bZ083149Vd_DC8vb-6fIhNItIuzgsqBBQG0Rgc0FiA0XmCWV4ILiSSzikf5MBlmuSmxESOE56NgaPkKLIMeJ8drLlT177PyHfqtZ25JqxUOQAGd1IEkViLjGu9d1SqqbMT7RYKQS2jU6vo1DIXhahW0Ske5i7WcxQczC055Y2l4Liwjkynitb-Szj_QzC1bZbRvdGC_O9fUflEwRqyZCCuCJx_A6IbiVA</recordid><startdate>20111015</startdate><enddate>20111015</enddate><creator>Burns, August</creator><creator>Sanghvi, Harshad</creator><creator>Lu, Ricky</creator><creator>Gaffikin, Lynne</creator><creator>Blumenthal, Paul</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20111015</creationdate><title>Single-disease health campaigns: the case of cervical cancer – Authors' reply</title><author>Burns, August ; Sanghvi, Harshad ; Lu, Ricky ; Gaffikin, Lynne ; Blumenthal, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c254t-9ded50dc11cc18eb50ca92179d53561ea9e989036429cf126b237b03163157703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acetic acid</topic><topic>Carbon dioxide</topic><topic>Cervical cancer</topic><topic>Costs</topic><topic>Developing countries</topic><topic>Disease</topic><topic>Health promotion</topic><topic>Health services</topic><topic>Human papillomavirus</topic><topic>Internal Medicine</topic><topic>LDCs</topic><topic>Mortality</topic><topic>Reproductive health</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burns, August</creatorcontrib><creatorcontrib>Sanghvi, Harshad</creatorcontrib><creatorcontrib>Lu, Ricky</creatorcontrib><creatorcontrib>Gaffikin, Lynne</creatorcontrib><creatorcontrib>Blumenthal, Paul</creatorcontrib><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Health Management</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burns, August</au><au>Sanghvi, Harshad</au><au>Lu, Ricky</au><au>Gaffikin, Lynne</au><au>Blumenthal, Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single-disease health campaigns: the case of cervical cancer – Authors' reply</atitle><jtitle>The Lancet (British edition)</jtitle><date>2011-10-15</date><risdate>2011</risdate><volume>378</volume><issue>9800</issue><spage>1378</spage><epage>1378</epage><pages>1378-1378</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>[...] the best-case scenario presented is a decline of 30% in cervical cancer deaths. Visual inspection with acetic acid (VIA) or human papillomavirus (HPV) vaccine programmes save money.2 The US$0.23 figure mentioned covers materials for screening and treatment (cotton, vinegar, batteries, CO2).3 VIA requires only a flashlight; cryotherapy requires no electricity.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/S0140-6736(11)61610-3</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-6736 |
ispartof | The Lancet (British edition), 2011-10, Vol.378 (9800), p.1378-1378 |
issn | 0140-6736 1474-547X |
language | eng |
recordid | cdi_proquest_journals_900104665 |
source | Elsevier ScienceDirect Journals Complete; ProQuest Central |
subjects | Acetic acid Carbon dioxide Cervical cancer Costs Developing countries Disease Health promotion Health services Human papillomavirus Internal Medicine LDCs Mortality Reproductive health Womens health |
title | Single-disease health campaigns: the case of cervical cancer – Authors' reply |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T18%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single-disease%20health%20campaigns:%20the%20case%20of%20cervical%20cancer%20%E2%80%93%20Authors'%20reply&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Burns,%20August&rft.date=2011-10-15&rft.volume=378&rft.issue=9800&rft.spage=1378&rft.epage=1378&rft.pages=1378-1378&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(11)61610-3&rft_dat=%3Cproquest_cross%3E2492178231%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=900104665&rft_id=info:pmid/&rft_els_id=1_s2_0_S0140673611616103&rfr_iscdi=true |